Tecumseh Urgent Care and Walk-In Clinic PC
Tecumseh Urgent Care and Walk-In Clinic PC was paid $728K by Medicaid between Nov 2020 and Nov 2024, across 17 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 25% of everything it billed.
TECUMSEH, MI 49286
Next to other Urgent Care Clinic/Center providers in Michigan
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 360 | $14K | |
| 2021 | 5,691 | $230K | |
| 2022 | 5,520 | $239K | |
| 2023 | 3,544 | $138K | |
| 2024incomplete | 3,013 | $107K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 25% | 2,847 | 2,840 | $181K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 2,971 | 2,767 | $157K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 2,153 | 2,039 | $154K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15% | 1,191 | 1,188 | $109K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.1% | 1,350 | 1,293 | $37K |
| 99000 | 2.8% | 3,512 | 3,310 | $20K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 1,481 | 1,435 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 382 | 365 | $13K |
| 87428 | 1.5% | 488 | 471 | $11K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.4% | 334 | 316 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 749 | 380 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 153 | 149 | $4K |
5 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 34 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 151 | $1K |
| 81002 | <1% | 306 | $786.95 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $66.49 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $16.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.